Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Development of Ms Budget Manager: A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms).
Therapy of NMO spectrum disorders.
Effects of Eight-week Resistance Training Program in Men With Multiple Sclerosis.
Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
Microglia-Mediated Inflammation and Neurodegenerative Disease.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
Admission sodium level and prognosis in adult Guillain-Barré syndrome.
CNS myelin structural modification induced in vitro by phospholipases A2.
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.
Patterns Of Use Of Tests To Monitor Disease Activity Among Patients Currently Treated For Relapsing Remitting Multiple Sclerosis (Rrms) In Europe.
Fatigue and heat sensitivity in patients with multiple sclerosis.
Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions.
Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects.
Demyelinating diseases in Asia.
Application of the 2012 revised diagnostic definitions for paediatric multiple sclerosis and immune-mediated central nervous system demyelination disorders.
Protein misfolding and clearance in demyelinating peripheral neuropathies: Therapeutic implications.
Influence of Formal Education on Cognitive Reserve in Patients with Multiple Sclerosis.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Deep morphea induced by interferon-β1b injection.
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Budget Impact Analysis of Delayed-Release Dimethylfumarate In The Treatment of Relapsing-Remitting Multiple Sclerosis In Italy.
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
Highly polarized Th17 cells induce EAE via a T-bet-independent mechanism.
Pages
« first
‹ previous
…
675
676
677
678
679
680
681
682
683
…
next ›
last »